Concourse Financial Group Securities, Inc. Genfit S.A. Transaction History
Concourse Financial Group Securities, Inc.
- $1.56 Billion
- Q2 2024
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding GNFT
# of Institutions
8Shares Held
49.2KCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY32.8KShares$195,6010.0% of portfolio
-
Old Mission Capital LLC12.8KShares$76,5170.0% of portfolio
-
Optiver Holding B.V. Amsterdam, P72.24KShares$13,3900.0% of portfolio
-
Rhumbline Advisers Boston, MA678Shares$4,0470.0% of portfolio
-
Ubs Group Ag346Shares$2,0650.0% of portfolio
About Genfit S.A.
- Ticker GNFT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,815,500
- Market Cap $297M
- Description
- Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...